Products

AG01BD2N

Name: Quinapril hydrochloride
Brand: Angene Chemical
SKU: AG01BD2N

82586-55-8 | Quinapril hydrochloride

Chemical structure of Quinapril hydrochloride, CAS 82586-55-8

AG01BD2N

SDS

COA

Price

$0.00

Add to Cart

WARNING This product is not for human or veterinary use.

Request For Quotation

CAS Number	82586-55-8
Catalog Number	AG01BD2N(AGN-PC-0UML00)
Chemical Name	Quinapril hydrochloride
IUPAC Name	(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
InChI	InChI=1S/C25H30N2O5.ClH/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30;/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30);1H/t17-,21-,22-;/m0./s1
InChI Key	IBBLRJGOOANPTQ-JKVLGAQCSA-N
MDL Number	MFCD00889215
Molecular Formula	C25H31ClN2O5
Molecular Weight	474.9770
NSC Number	758222
SMILES	O=C([C@H]1N(C([C@@H](N[C@H](C(OCC)=O)CCC2=CC=CC=C2)C)=O)CC3=C(C=CC=C3)C1)O.Cl
UNII	33067B3N2M
Synonyms	2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, Accupril, CI 906, CI-906, PD 109,452 2, PD 109452 2, PD 109452-2, PD 1094522, PD-109,452-2, quinapril, quinapril hydrochloride, QUINAPRIL HYDROCHLORIDE, 82586-55-8, Accupril, QUINAPRIL HCL, Accuprin, Acequin, Quinazil, Korec, Hemokvin, Lidaltrin, Acuitel, Ectren, Conan, CI-906, Quinapril (hydrochloride), Accupron, Acuprel, Continucor, Koretic, Asig, Accupro, Accuretic, Quinapril.HCl, UNII-33067B3N2M, HSDB 7046, CI906, Quinapril hydrochloride, PD 109452-2, CHEBI:8714, Quinapril hydrochloride (Accupril), MFCD00889215, 33067B3N2M, DSSTox_CID_1221, DSSTox_RID_76019, DSSTox_GSID_21221, (3S)-2-[(2S)-2-{[(2S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YL]AMINO}PROPANOYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE, (S)-2-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, 1-ethyl ester, monohydrochloride, 3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (3S-(2(R(R)),3R))-, (3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride, (S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride, 3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3S-(2(R(R)),3R)), CAS-82586-55-8, pd-109452-2, Quinapril hydrochloride [USAN], Quinapril N-Oxide, NCGC00094997-01, Accupril (TN), (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride, Quinapril hydrochloride [USAN:USP], CI 906, Quinapril hydrochloride;, AC1L1HXI, PD-109,452-2, SCHEMBL41404, MLS001076683, C25H30N2O5.HCl, Quinapril Hydrochloride ,(S), SPECTRUM1503076, quinapril-hydrochloride-accupril, CHEMBL1201011, DTXSID3021221, IBBLRJGOOANPTQ-JKVLGAQCSA-N, HMS1922C15, Pharmakon1600-01503076, tetrahydroisoquinoline-3-carboxylic, (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid Hydrochloride, HY-B0477, quinapril hydrochloride hydrochloride, 2-ylamino)propanoyl)-1,2,3,4-, Tox21_111381, Tox21_200390, CCG-39543, NSC758222, Quinapril hydrochloride (JP17/USP), s2581, AKOS015888532, Tox21_111381_1, AB07655, AC-1655, CS-2591, MCULE-2623123657, NC00722, NE45380, NSC-758222, NCGC00167962-06, NCGC00257944-01, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, 3-Isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3S-(2(R(R)),3R))-, AN-14706, AS-14026, BC206223, CPD000499582, LS-85471, SAM002589972, SC-17215, SMR000499582, AB2000675, PD-109522, SW199393-2, CI-906 (CN-109452), A11736, C07340, D00459, Quinapril hydrochloride, >=98% (HPLC), solid, 586Q558, SR-01000765404, SR-01000765404-2, (S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-, monohydrochloride,(3s-(2(r(r)),3r))-henylpropyl)amino)-1-oxopropyl), Quinapril hydrochloride, European Pharmacopoeia (EP) Reference Standard, Quinapril hydrochloride, United States Pharmacopeia (USP) Reference Standard, 3-isoquinolinecarboxylicacid,1,2,3,4-tetrahydro-2-(2-((1-(ethoxycarbonyl)-3-p, Quinapril for peak identification, European Pharmacopoeia (EP) Reference Standard, Quinapril for system suitability, European Pharmacopoeia (EP) Reference Standard, Quinapril Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, (3S)-2-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride, (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid hydrochloride, (3S)-2-{(2S)-2-[(1S)-1-ethoxycarbonyl-3-phenylpropylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride, (3S)-2-{N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride, (3S-(2(R(R)),3R))-2-(2-((1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)AMINO)-1-OXOPROPYL)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACID MONOHYDROCHLORIDE, (S)-2-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride, (S)-2-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid 1-Ethyl Ester Hydrochloride, [3S-[2[R(R)], 3R]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, monohydrochloride, 3-isoquinolineacrboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3S-(2(R(R)),3R*))-, quinapril, Mixture Name, acid hydrochloride, CID54891, C25-H30-N2-O5.Cl-H, CS-O-10225, PD 1094522, PD 109452 2, PD 109,452 2, C041125, D000077583, 85441-61-8, (3S)-2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, hydrochloride (1:1), 3-Isoquinolinecarboxylic acid, 2-((2S)-2-(((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3S)-,

Complexity	648
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	3
Defined Bond Stereocenter Count	0
Exact Mass	474.192g/mol
Formal Charge	0
Heavy Atom Count	33
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	474.982g/mol
Monoisotopic Mass	474.192g/mol
Rotatable Bond Count	10
Topological Polar Surface Area	95.9A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Related Research Chemicals

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited